Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Operating Income (2023 - 2025)

Metagenomi (MGX) has disclosed Operating Income for 3 consecutive years, with -$24.4 million as the latest value for Q4 2025.

  • Quarterly Operating Income fell 18.15% to -$24.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$96.0 million through Dec 2025, down 8.0% year-over-year, with the annual reading at -$96.0 million for FY2025, 8.0% down from the prior year.
  • Operating Income for Q4 2025 was -$24.4 million at Metagenomi, down from -$22.8 million in the prior quarter.
  • The five-year high for Operating Income was -$16.9 million in Q2 2024, with the low at -$29.0 million in Q1 2024.
  • Average Operating Income over 3 years is -$22.0 million, with a median of -$21.7 million recorded in 2024.
  • Peak annual rise in Operating Income hit 6.12% in 2024, while the deepest fall reached 61.85% in 2024.
  • Over 3 years, Operating Income stood at -$20.2 million in 2023, then decreased by 2.11% to -$20.6 million in 2024, then decreased by 18.15% to -$24.4 million in 2025.
  • According to Business Quant data, Operating Income over the past three periods came in at -$24.4 million, -$22.8 million, and -$21.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.